Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop. Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop.

Slides:

Advertisements

Similar presentations

Chapter 16 Chapter 16 Phosphatonins Copyright © 2013 Elsevier Inc. All rights reserved.

Advertisements

Volume 68, Pages S24-S28 (July 2005)

Volume 79, Pages S3-S8 (April 2011)

Vitamin D3 Presented by John Lear.

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K.

Modification of the trade-off hypothesis of Slatopolsky and Bricker as it relates to the adaptation of the body to decreased functional renal mass in an.

Control of Gene Expression

Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).

Volume 67, Pages S1-S7 (June 2005)

Volume 86, Issue 6, Pages (December 2014)

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Agents That Affect Bone Mineral Homeostasis

Electrolyte Disorders Associated With Cancer

Volume 73, Issue 1, Pages 3-5 (January 2008)

Fibroblast Growth Factor 23 and CKD Prognosis

Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis

Phosphorus: Another Devil in Our Diet?

FGF23 or PTH: which comes first in CKD ?

Figure 4 Model of changes in the serum levels

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K.

Volume 78, Issue 10, Pages (November 2010)

FGF23–parathyroid interaction: implications in chronic kidney disease

Volume 85, Issue 5, Pages (May 2014)

Volume 79, Pages S24-S27 (April 2011)

Volume 92, Issue 1, Pages (July 2017)

Volume 79, Pages S3-S8 (April 2011)

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Tally Naveh-Many, Justin Silver Kidney International

Fibroblast growth factor-23 and Klotho in chronic kidney disease

Volume 79, Pages S20-S23 (April 2011)

New vitamin D analogs Kidney International

Use of vitamin D in chronic kidney disease patients

Florian Lang, Michael Föller Kidney International

Volume 67, Pages S33-S36 (June 2005)

Volume 75, Issue 11, Pages (June 2009)

ARNT as a Novel Antifibrotic Target in CKD

Volume 80, Issue 5, Pages (September 2011)

Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism

Volume 68, Pages S24-S28 (July 2005)

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Volume 87, Issue 3, Pages (March 2015)

Volume 61, Issue 5, Pages (May 2002)

Volume 66, Pages S13-S19 (October 2004)

Volume 75, Issue 9, Pages (May 2009)

Fibroblast growth factor 23: the making of a hormone

Figure 1 Altered modes of cAMP signalling at PTHR1

Phosphate and the parathyroid

Guang-Huar Young, Vin-Cent Wu Kidney International

Latest findings in phosphate homeostasis

Volume 71, Issue 8, Pages (April 2007)

Pablo A. Ureña Torres, Marc De Broe Kidney International

Molecular origin of the kidney clock

Mineral metabolism in CKD: adaptation devolves into maladaptation.

Volume 69, Issue 1, Pages (January 2006)

Increased parathyroid expression of klotho in uremic rats

Volume 65, Issue 3, Pages (March 2004)

The ins and outs of phosphate homeostasis

Volume 60, Issue 5, Pages (November 2001)

Diagram of the mechanisms involved in limiting the ability of the kidney to maintain the levels of 1,25-dihydroxyvitamin D in chronic kidney disease (CKD).

PTH response to the predialysis serum calcium concentration in hemodialysis patients with severe (A), moderate (B), and mild (C) hyperparathyroidism. PTH.

(Top) Micrographs of SNAIL-HA and mock-infected cells.

Volume 74, Issue 10, Pages (November 2008)

Volume 55, Issue 4, Pages (April 1999)

Volume 61, Issue 4, Pages (April 2002)

Marta Christov, Harald Jüppner Kidney International

Volume 87, Issue 6, Pages (June 2015)

Urea transport across an IMCD cell.

Tamara Isakova, Orlando M. Gutiérrez, Myles Wolf Kidney International

Volume 86, Issue 2, Pages (August 2014)

Regulation of serum calcium homeostasis.

Presentation transcript:

Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop. Parathyroid hormone (PTH) -fibroblast growth factor 23 (FGF23) feedback loop. PTH binds to the parathyroid hormone receptor (PTH1R) on osteocytes and osteoblasts and activates protein kinase A (PKA), which increases nuclear receptor–associated protein 1 (Nurr1) expression. Nurr1 then binds to defined nerve growth factor-induced clone B response elements in the FGF23 promoter and induces FGF23 transcription. FGF23, in turn, inhibits PTH production. In CKD, however, hyperparathyroidism increases Nurr1 and FGF23 expression, but downregulation of the FGF23 receptor complex (Klotho-fibroblastic growth receptor 1 [FGFR1]) makes the parathyroid gland (PTG) and kidney resistant to the actions of FGF23. Calcimimetics decrease PTH, Nurr1, and FGF23. Modified from reference 36, with permission. Cynthia S. Ritter, and Eduardo Slatopolsky CJASN 2016;11:1088-1100 ©2016 by American Society of Nephrology